Searchable abstracts of presentations at key conferences in endocrinology

ea0059p121 | Neoplasia, cancer & late effects | SFEBES2018

Progestin-induced breast cancer: Identifying the role of progesterone receptor isoforms

Cartwright Meghan , Louw-du Toit Renate , Africander Donita

Breast cancer is the most common oncology-related cause of death in women worldwide. The use of progestins in combined hormone replacement therapy (HRT) has been implicated in increasing the risk of developing breast cancer in postmenopausal women. Since various progestins are available for clinical use, all differentiated by structure, it is possible that not all progestins would lead to increased breast cancer risk. Progestins are synthetic ligands of the progesterone recept...

ea0070aep776 | Pituitary and Neuroendocrinology | ECE2020

To optimize the acute octreotide suppression test in predicting the efficacy of long acting somatostatin analogues in acromegaly

Yuting Gao , Liao Zhihong , Du Qin , Cai Ke

A 6-hour octreotide suppression test (OST) is useful in the selection of patients with acromegaly for chronic somatostatin depot analogues treatment. However, it is time consuming and that brings inconvenience to patients. We aim to simplify the blood sampling of OST, and determine the reliability of a short version of the classic 6-hour OST. The data provided in the supplementary tables of the primary manuscript were used to re-analyze the efficacies of the simplified OST tes...

ea0070aep848 | Reproductive and Developmental Endocrinology | ECE2020

Serum inhibin B level distinguishes congenital hypogonadotropic hypogonadism from constitutional delay of growth and puberty in males: A systematic review and meta-analysis

Yuting Gao , Du Qin , Liu Liyi , Liao Zhihong

Objective: The distinction between constitutional delay of growth and puberty (CDGP) and congenital hypogonadotropic hypogonadism (CHH) in males with delayed puberty is difficult but important for timely treatment. We aimed to summarize the sensitivity and specificity of serum inhibin B (INHB) level in distinguishing CHH with CDGPin boys.Methods: Studies in the PubMed, EMBASE and Cochrane Library databases were systematically searched from the date of da...

ea0029p1227 | Obesity | ICEECE2012

Preventing childhood obesity by community based intervention approaches

Borys J. , du Plessis H. , Walter L. , Harper P.

Introduction: EPODE is a coordinated, capacity-building approach for communities to implement effective and sustainable strategies to prevent childhood obesity.Methods: At central level, a coordination team using social marketing and organizational techniques trains and coaches a local project manager nominated in each EPODE town by the local authorities. The local project manager is also provided with tools to mobilize local stakeholders through a local...

ea0029p1271 | Obesity | ICEECE2012

Obesity prevention: main findings of the EPODE European network project

Borys J. , du Plessis H. , Walter L. , Harper P.

Introduction: EPODE is a coordinated, capacity-building methodology for communities to implement effective and sustainable strategies to prevent childhood obesity. Since 2008, the EPODE European Network (EEN), supported by the European Commission (DG SANCO), is aimed at facilitating the implementation of interventions using the EPODE methodology in other regions and countries.Methodology: From 2008 to 2011, four committees – gathering universities a...

ea0056p345 | Diabetes (to include epidemiology, pathophysiology) | ECE2018

Telmisartan increases gluconeogenesis by inducing PKCζ-Thr410 phosphorylation in hyperglycemia-treated HepG2 cells and high-fat diet-fed mouse liver

Cho Du-Hyong , Cho Kae Won , Song Kee-Ho

Telmisartan, an angiotensin II type 1 receptor blocker (ARB), is widely prescribed for the treatment of hypertensive patients with simultaneous diabetes mellitus (DM). Unlike other ARBs, telmisartan is reported to have various ancillary effects as well as common blood pressure-lowering effect. In this regard, telmisartan improves endothelial dysfunction and cardiovascular complications in DM patients and is recently reported to reduce new-onset DM incidence. However, effects a...

ea0081p668 | Pituitary and Neuroendocrinology | ECE2022

Ultrasound of the median nerve in acromegalic patients : changes at 1 year follow up

Sagova Ivana , Pavai Dušan , Mokaň Marian , Vaňuga Peter

Background: The aim of our study was to asses changes in the cross sectional area (CSA) of the median nerve by ultrasound in newly diagnosed acromegalic patients 1 year after treatment of acromegaly (transsphenoidal surgery, somatostatine analogues).Patients and methods: The study included 30 newly diagnosed acromegalic patients (18 females and 12 males) and 30 healthy controls (18 females and 12 males) matched for age, gender and body mass index. Clinic...

ea0081ep151 | Calcium and Bone | ECE2022

Sex differences of the reaction of undercarboxylated osteocalcin to hypoglycaemia

Pospisilova Hana , Duškova Michaela , Kolatorova Lucie , Jandikova Hana , Starka Luboslav

In recent years, there has been increasing evidence for the hypothesis of bones as endocrine organs. Osteocalcin, long considered just a marker of new bone formation, is now seen as the first hormone produced by bones, and seems to be associated with regulating glucose metabolism and reproduction. The aim of this work was to monitor changes of osteocalcin in reaction to hypoglycaemia, and determine if there are differences in such reactions between the sexes. The study include...

ea0067o7 | Oral Presentations | EYES2019

Coexistence of medullary carcinoma and papillary carcinoma of the thyroid in a 35 year old patient with RET protooncogene mutation

Nuţu Flavia Giselle , Duşceac Roxana , Poiană Cătălina

Background: Medullary and papillary thyroid carcinomas are distinct entities, regarding their incidence, cellular and genetic origin, histopathological features and prognosis, but there have been described a few cases of the two occurring simultaneously in the same patient. Medullary thyroid carcinoma represents between 1–5% of all thyroid malignancies and it is responsible for 12–13% of all cancer related deaths. The familial form (10–20% of the cases) is cause...

ea0063gp225 | Adrenal and Neuroendocrine - Clinical (1) | ECE2019

Activation of the ATM/Akt/CREB/eNOS expression signaling axis by aphidicolin increases nitric oxide production to attenuate endothelial cell death

Cho Du-Hyong , Park Jung-Hyun , Lee Jee Young , Lee Hyeon-Ju , Jo Inho

Previously, we reported that aphidicolin acutely increases nitric oxide (NO) production in bovine aortic endothelial cells (BAECs) by increasing phosphorylation of endothelial nitric oxide synthase at serine 1179 (p-eNOS-Ser1179) and decreasing phosphorylation at serine 116 (p-eNOS-Ser116) without altering eNOS protein expression. Here, we demonstrate that prolonged treatment with aphidicolin (over 24 h) also increased NO production in BAECs. Unlike the a...